Coronavirus (COVID-19): visiting The Royal Marsden suspended

Coronavirus (COVID-19) latest: Visiting The Royal Marsden is still suspended, but we want to reassure our patients, their families and anyone worried about cancer during this difficult time that we are still delivering treatment - the hospital is open. Please see more information here about how we are keeping everyone safe.

Dr Imogen Locke

Consultant Clinical Oncologist MBBS MD BSc MRCP FRCR

Specialism: Breast, Lung, Radiotherapy, Skin

Available at: Chelsea, Sutton

Special interests:

  • breast radiotherapy 
  • lung radiotherapy, including stereotactic radiotherapy 
  • clinical audit and quality improvement activity


Dr Locke has both a private and an NHS practice at The Royal Marsden.

The service offers a comprehensive range of cutting edge radiotherapy treatments including Intensity Modulated Radiotherapy (IMRT), Image Guided Radiotherapy (IGR), stereotactic radiotherapy and brachytherapy. She specialises in the treatment of breast and lung cancer.

She qualified at St Bartholomew’s Hospital, London in 1994 and her subsequent oncological training was in London. She undertook research at The Institute of Cancer Research between 2003 and 2006, and was awarded an MD in 2008. Her research focused on the role of ductal lavage in the molecular risk assessment of women carrying germline mutations in the BRCA1 and BRCA2 genes who are at increased risk for developing breast cancer.

Her current interests include the development of heart-sparing radiotherapy techniques for the treatment of breast cancer, stereotactic radiotherapy for the treatment of early-stage lung cancer and quality improvement activity.

Clinical units